- Home
- CYCN vs FRSX Comparison
CYCN vs FRSX Comparison
Compare CYCN & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CYCN | FRSX |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5M | 5.6M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | CYCN | FRSX |
|---|---|---|
| Price | $1.54 | $1.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 4.4M | 101.0K |
| Earning Date | 03-03-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,855,000.00 | $452,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1371.65 | N/A |
| 52 Week Low | $1.16 | $1.26 |
| 52 Week High | $6.25 | $11.47 |
Technical Indicators
Market Signals| Indicator | CYCN | FRSX |
|---|---|---|
| Relative Strength Index (RSI) | 48.32 | 34.45 |
| Support Level | $1.58 | $1.36 |
| Resistance Level | $2.00 | $1.43 |
| Average True Range (ATR) | 0.18 | 0.08 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 32.23 | 38.71 |
Price Performance
Historical ComparisonAbout CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.